Pink SheetScripMedtech InsightHBW InsightGenerics BulletinIn Vivo

Generics Bulletin

Medtech Insight

FDA Presses Domestic Manufacturers To Engage In Remote Regulatory Assessments In Lieu Of Inspections

Apr 22 2021

• By Shawn M. Schmitt

Two people meet virtually.

Related Content

FDA Plans To Improve COVID-19 EUA Process, Inspection Work Based On Report Recommendation

Apr 09 2021

QA/RA Outlook 2021: 4 Hotspots To Watch, From ‘Hybrid’ US FDA Inspections To QSR Harmonization

Feb 05 2021

On-Site Inspections Of US Device Makers Plummet 93% As FDA Scrambles For Virtual Solutions

Dec 01 2020

Compliance Corner: How To Survive An FDA ‘Desk Audit’ During The COVID-19 Crisis

Apr 15 2020

Photos Snapped During FDA Device Inspections: Fair Game Or Agency Overreach?

Feb 09 2016

Additional Topics

United States International FDA Enforcement Compliance Quality Control Medical Device

More from Regulation

More from Policy & Regulation

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window